Loading clinical trials...
Loading clinical trials...
A Two-part, Double-blind, Placebo-controlled, Phase I Study of the Safety and Pharmacokinetics of Single Doses of GT300 in Healthy Subjects
Conditions
Interventions
GT300
Microcrystalline cellulose
Start Date
August 23, 2021
Primary Completion Date
February 15, 2022
Completion Date
March 15, 2022
Last Updated
July 15, 2021
NCT07545473
NCT07449117
NCT05847985
NCT06057909
NCT04715399
NCT06785948
Lead Sponsor
Generian Pharmaceuticals, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions